Erratum: Sustained endothelial expression of HoxA5 in vivo impairs pathological angiogenesis and tumor progression (PLoS ONE (2015) 10: 3 (E0121720) DOI: 10.1371/journal.pone.0121720);Sustained endothelial expression of HoxA5 in vivo impairs pathological angiogenesis and tumor progression

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Cuevas, Ileana ^a   Layman, Hans ^a   Coussens, Lisa ^b   Boudreau, Nancy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOX PROTEIN; HOXA5 PROTEIN; THROMBOSPONDIN 2; UNCLASSIFIED DRUG; VASCULOTROPIN; HOMEODOMAIN PROTEIN; HOXA5 PROTEIN, MOUSE; PHOSPHOPROTEIN; THROMBOSPONDIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSPLASIA; ENDOTHELIUM CELL; GENE EXPRESSION; GENE TRANSFER; IN VIVO STUDY; MAST CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TRANSGENE; TUMOR GROWTH; TUMOR VASCULARIZATION; WOUND HEALING; ANIMAL; CARCINOGENESIS; DISEASE COURSE; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); ONCOGENESIS AND MALIGNANT TRANSFORMATION; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PRECANCER; SKIN TUMOR; TRANSGENIC MOUSE; VIROLOGY;

MUS; MUS MUSCULUS;

ANIMALS; CARCINOGENESIS; DISEASE PROGRESSION; ENDOTHELIAL CELLS; HOMEODOMAIN PROTEINS; HUMAN PAPILLOMAVIRUS 16; MICE; MICE, TRANSGENIC; NEOPLASTIC PROCESSES; NEOVASCULARIZATION, PATHOLOGIC; PAPILLOMAVIRUS INFECTIONS; PHOSPHOPROTEINS; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS; THROMBOSPONDINS; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84926443254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148833     Document Type: Erratum

References (44)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660. PMID: 12778163
2. Casanovas O, Hicklin DJ, Bergers G, Hanahan D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 2005; 8: 299-309. PMID: 16226705
3. Boudreau N, Andrews C, Srebrow A, Ravanpay A, Cheresh DA. Induction of the angiogenic phenotype by Hox D3. J Cell Biol 1997; 139: 257-264. PMID: 9314544
4. Boudreau NJ, Varner JA. The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis. J Biol Chem 2004; 279: 4862-4868. PMID: 14610084
5. Mace KA, Hansen SL, Myers C, Young DM, Boudreau N. HOXA3 induces cell migration in endothelial and epithelial cells promoting angiogenesis and wound repair. J Cell Sci 2003; 118: 2567-2577.
6. Myers C, Charboneau A, Boudreau N. Homeobox B3 promotes capillary morphogenesis and angiogenesis. J Cell Biol 2000; 148: 343-351. PMID: 10648567
7. Myers C, Charboneau A, Cheung I, Hanks D, Boudreau N. Sustained expression of homeobox D10 inhibits angiogenesis. Am J Pathol 2002; 161: 2099-2109. PMID: 12466126
8. Rhoads K, Arderiu G, Charboneau A, Hansen SL, Hoffman W, Boudreau N. A role for Hox A5 in regulating angiogenesis and vascular patterning. Lymphat Res Biol 2005; 3: 240-252. PMID: 16379594
9. Arderiu G, Cuevas I, Chen A, Carrio M, Eaast L, Boudreau N. HoxA5 stabilizes Adherens Junctions via increased Akt1. Cell Adh Migr 2007; 1: 185-195. PMID: 19262140
10. Aubin J, Lemieux M, Tremblay M, Berard J, Jeannotte L. Early postnatal lethality in Hoxa-5 mutant mice is attributable to respiratory tract defects. Dev Biol 1997; 192: 432-445. PMID: 9441679
11. Aubin J, Chailler P, Menard D, Jeannotte L. Loss of Hoxa5 gene function in mice perturbs intestinal maturation. Am J Physiol 1997; 277: C965-973.
12. Carlson TR, Yan Y, Wu X, Lam MT, Tang GL, Beverly LJ, et al. Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci U S A 2005; 102: 9884-9889. PMID: 15994223
13. Coussens LM, Hanahan D, Arbeit JM. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am J Pathol 1996; 149: 1899-1917. PMID: 8952526
14. Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, et al. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 2002; 8: 27-34. PMID: 11786903
15. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286: 2511-2514. PMID: 10617467
16. Hansen SL, Myers CA, Charboneau A, Young DM, Boudreau N. HoxD3 accelerates wound healing in diabetic mice. Am J Pathol 2003; 163: 2421-2431. PMID: 14633614
17. Andreu P, Johansson M, Affara NI, Pucci F, Tan T, Junankar S et al. FcRgamma activation regulates in-flammation-associated squamous carcinogenesis. Cancer Cell 2010; 17: 121-134. doi: 10.1016/j.ccr.2009.12.019 PMID: 20138013
18. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes & development 1999; 13: 1382-1397.
19. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103: 481-490. PMID: 11081634
20. de Visser KE, Korets LV, Coussens LM. Early neoplastic progression is complement independent. Neoplasia 2004; 6: 768-776. PMID: 15720803
21. de Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005; 7: 411-423. PMID: 15894262
22. van Kempen LC, Coussens LM. MMP9 potentiates pulmonary metastasis formation. Cancer Cell 2002; 2: 251-252. PMID: 12398887
23. Arbeit JM, Munger K, Howley PM, Hanahan D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol 1994; 68: 4358-4368. PMID: 7515971
24. Tonnesen MG, Feng X, Clark RA. Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000; 5: 40-46. PMID: 11147674
25. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992; 12: 954-961. PMID: 1312220
26. Hong YK, Lange-Asschenfeldt B, Velasco P, Hirakawa S, Kunstfeld R, Brown LF, et al. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J 2004; 18: 1111-1113. PMID: 15132990
27. Jacobi J, Tam BY, Sundram U, von Degenfeld G, Blau HM, Kuo CJ, et al. Discordant effects of a soluble VEGF receptor on wound healing and angiogenesis. Gene Ther 2004; 11: 302-309. PMID: 14737090
28. Agah A, Kyriakides TR, Letrondo N, Bjorkblom B, Bornstein P. Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis. Matrix Biol 2004; 22: 539-547. PMID: 14996433
29. Eichten A, Hyun WC, Coussens LM. Distinctive features of angiogenesis and lymphangiogenesis determine their functionality during de novo tumor development. Cancer Res 2007; 67: 5211-5220. PMID: 17545601
30. Mace KA, Restivo TE, Rinn JL, Paquet AC, Chang HY, Young DM, et al. HOXA3 modulates injury-induced mobilization and recruitment of bone marrow-derived cells. Stem Cells 2009; 27: 1654-1665. doi: 10.1002/stem.90 PMID: 19544454
31. Jeannotte L, Lemieux M, Charron J, Poirier F, Robertson EJ. Specification of axial identity in the mouse: role of the Hoxa-5 (Hox1.3) gene. Genes Dev 1993; 7: 2085-2096. PMID: 7901120
32. Aubin J, Dery U, Lemieux M, Chailler P, Jeannotte L. Stomach regional specification requires Hoxa5-driven mesenchymal-epithelial signaling. Development 2002; 129: 4075-4087. PMID: 12163410
33. Meunier D, Aubin J, Jeannotte L. Perturbed thyroid morphology and transient hypothyroidism symptoms in Hoxa5 mutant mice. Dev Dyn 2003; 227: 367-378. PMID: 12815622
34. Garin E, Lemieux M, Coulombe Y, Robinson GW, Jeannotte L. Stromal Hoxa5 function controls the growth and differentiation of mammary alveolar epithelium. Dev Dyn 2006; 235: 1858-1871. PMID: 16607641
35. Krieger KE, Abbott MA, Joksimovic M, Lueth PA, Sonea IM, Jeannotte L, et al. Transgenic mice ectopically expressing HOXA5 in the dorsal spinal cord show structural defects of the cervical spinal cord along with sensory and motor defects of the forelimb. Brain Res Dev Brain Res 2004; 150: 125-139. PMID: 15158076
36. Fuller JF, McAdara J, Yaron Y, Sakaguchi M, Fraser JK, Gasson JC. Characterization of HOX gene expression during myelopoiesis: role of HOX A5 in lineage commitment and maturation. Blood 1999; 93: 3391-3400. PMID: 10233891
37. Crooks GM, Fuller J, Petersen D, Izadi P, Malik P, Pettengale PK, et al. Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors. Blood 1999; 94: 519-528. PMID: 10397719
38. Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000; 405: 974-978. PMID: 10879542
39. Golpon HA, Geraci MW, MooreMD, Miller HL,Miller GJ, Tuder RM, et al. HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol 2001; 158: 955-966. PMID: 11238043
40. Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008; 111: 1217-1226. PMID: 17957028
41. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005; 8: 211-226. PMID: 16169466
42. Coffelt SB, Tal AO, Scholz A, De Palma M, Patel S, Urbich C, et al. Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Cancer Res 2010; 70: 5270-5280. doi: 10.1158/0008-5472.CAN-10-0012 PMID: 20530679
43. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119(6): 1420-1428. doi: 10.1172/JCI39104 PMID: 19487818
44. Liang Y, Xia L, Du Z, Sheng L, Chen H, Chen G, et al. HoxA5 inhibits keratinocytes growth and epidermal formation in organotypic cultures in vitro and in vivo. J Dermatol Sci 2012; 66(3): 197-206. doi: 10.1016/j.jdermsci.2012.02.019 PMID: 22464764